PGL/PCC development has been related to mutations in three genes that cause well-known cancer susceptibility syndromes: VHL (von hippel-lindau tumor supressor), NF1 (neurofibromin 1), and RET (ret proto-oncogene). The gene discussed is NF1; the disease is cancer.